Cardinal Health to Acquire AccessClosure 
|
By HospiMedica International staff writers Posted on 20 Apr 2014 |
|
Image: The Mynx Ace vascular closure device (Photo courtesy of AccessClosure).
Cardinal Health (Dublin, OH, USA) has signed an agreement to acquire AccessClosure (Santa Clara, CA, USA), a manufacturer and distributor of extravascular closure devices, for USD 320 million.
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Resorbable Bovine Collagen Membrane
GenDerm
New
Pediatric Mask
Respire SOFT
Latest Business News
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
Channels
Artificial Intelligence
view channel
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read more
Facial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes
Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read more
Critical Care
view channel
Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly prevalent and often under-monitored because quantitative liver fat assessment is not routinely available at the bedside.... Read more
AI Method Turns Toe Scan into Rapid PAD Screening Tool
Peripheral artery disease (PAD) is caused by plaque buildup that restricts blood flow to the legs and can lead to limb loss. Many cases go undetected because diagnosis often requires a specialized visit... Read more
Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
Pulmonary conditions such as chronic obstructive pulmonary disease, lung nodules, and pulmonary embolism require rapid identification and coordinated follow-up across emergency, inpatient, and ambulatory settings.... Read more
Surgical Techniques
view channel
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
